Richard A. Kayne

Insider Reports History

Entity
Individual
Signature
/s/ Richard A. Kayne
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard A. Kayne:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eiger BioPharmaceuticals, Inc. 10%+ Owner Common Stock 5.38M $1.6M $0.30 Nov 2, 2023 Indirect

Insider Reports Filed by Richard A. Kayne

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EIGR Eiger BioPharmaceuticals, Inc. Oct 31, 2023 5 $72.8K 4 Nov 2, 2023 10%+ Owner
EIGR Eiger BioPharmaceuticals, Inc. Oct 18, 2023 0 $0 3 Oct 30, 2023 10%+ Owner